ORION Holdings Corp. Stock

Equities

A001800

KR7001800002

Food Processing

End-of-day quote Korea S.E. 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
14,170 KRW +0.35% Intraday chart for ORION Holdings Corp. +2.53% -2.95%
Sales 2022 2,935B 2.14B Sales 2023 2,954B 2.15B Capitalization 878B 639M
Net income 2022 103B 74.96M Net income 2023 85.62B 62.33M EV / Sales 2022 0.03 x
Net cash position 2022 823B 599M Net cash position 2023 1,033B 752M EV / Sales 2023 -0.05 x
P/E ratio 2022
8.97 x
P/E ratio 2023
10.3 x
Employees -
Yield 2022
4.56%
Yield 2023
5.14%
Free-Float 32.18%
More Fundamentals * Assessed data
Dynamic Chart
ORION Holdings Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
ORION Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
ORION Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Eion Corp announced that it has received $13.064976 million in funding from a group of investors CI
Eion Corp announces tranche update CI
Eion Corp announced that it expects to receive funding from a group of investors CI
ORION Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
ORION Holdings Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
ORION Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
ORION Holdings Corp. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Transcript : Orion Group Holdings, Inc., Q4 2021 Earnings Call, Mar 03, 2022
ORION Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Genomictree Inc. announced that it has received KRW 5.00000105 billion in funding from ORION Holdings Corp. CI
Genomictree Inc. announced that it expects to receive KRW 5.00000105 billion in funding from ORION Holdings Corp. CI
Shandong Lukang Biotechnology Development Co., Ltd. announced that it has received CNY 195 million in funding from Shandong Lukang Pharmaceutical Co.,Ltd., Orion Food Co., Ltd., ORION Holdings Corp. CI
More news
1 day+0.35%
1 week+2.53%
Current month+1.21%
1 month-1.32%
3 months+4.81%
6 months-7.39%
Current year-2.95%
More quotes
1 week
13 700.00
Extreme 13700
14 250.00
1 month
13 700.00
Extreme 13700
14 510.00
Current year
13 090.00
Extreme 13090
15 440.00
1 year
13 090.00
Extreme 13090
16 910.00
3 years
13 090.00
Extreme 13090
18 750.00
5 years
10 400.00
Extreme 10400
19 800.00
10 years
10 400.00
Extreme 10400
404 931.33
More quotes
Managers TitleAgeSince
Director/Board Member 60 15-01-31
Director/Board Member 64 14-06-30
Corporate Officer/Principal 68 75-01-31
Members of the board TitleAgeSince
Corporate Officer/Principal 68 80-03-31
Corporate Officer/Principal 68 75-01-31
Director/Board Member 64 14-06-30
More insiders
Date Price Change Volume
24-04-24 14,170 +0.35% 24,969
24-04-23 14,120 -0.49% 32,470
24-04-22 14,190 +3.12% 45,520
24-04-19 13,760 -0.36% 93,422
24-04-18 13,810 -0.07% 31,748

End-of-day quote Korea S.E., April 23, 2024

More quotes
Orion Holdings Corp is a Korea-based company mainly engaged in confectionery business. The Company operates its business through five segments. The Confectionary segment is engaged in the manufacture and sale of confectioneries and snacks such as biscuits and pies. The Video segment is mainly engaged in the businesses of investment and distribution of movies, planning and producing contents, and others. The Holding segment is mainly engaged in the businesses of selling brand royalties and renting buildings. The Other segment is mainly engaged in beverage business, information service business, investment and trade business. The Construction segment is engaged in construction and sales business. The Company sells products in domestic and overseas markets such as China and Southeast Asia.
More about the company
  1. Stock Market
  2. Equities
  3. A001800 Stock